NPS Pharmaceuticals, Inc. (Nasdaq: NPSP) provided an update regarding the status of its new drug application for PREOS.

This article: 169 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE